Navigation Links
Maryland Stem Cell Commission Issues Nationwide Request for Applications for New Post-Doctoral Fellowship Grants
Date:12/17/2007

COLUMBIA, Md., Dec. 17 /PRNewswire/ -- The Maryland Stem Cell Research Commission (Commission) today issued a Request for Applications (RFA) for new post-doctoral fellowship grants under RFA-MD-07-3. The Commission is soliciting nationwide applications from pre-doctoral students and post- doctoral fellows who wish to conduct basic and/or translational research on all types of human stem cells in Maryland.

It is estimated that up to 16 fellowships will be funded with each fellowship being awarded up to $55,000 per year for up to two years, which is inclusive of all direct, indirect and fringe benefits costs. Maryland-based organizations of all types are eligible as training institutes, including public and private, for-profit and non-profit, universities, colleges, research institutes, companies, medical centers, and others.

The Commission's goal in creating these fellowship grants is to grow the biotechnology community in Maryland by training the next generation of stem cell researchers. This addresses a purpose of the Maryland Research Stem Cell Act, which is to broaden and advance basic knowledge of human stem cell biology that will be relevant for eventual development of clinical applications, and to enable, support and accelerate such clinical applications for prevention, diagnosis and treatment of human diseases and conditions.

Applications for the fellowship should follow the guideline under the RFA- MD-07-3, and must be submitted electronically to TEDCO at mscrfinfo@MarylandTEDCO.org by 5 p.m. EST on Thursday, Jan. 31, 2008.

Applications will be evaluated based on the following: the applicant's qualifications and potential for stem cell research, the quality of the proposed training program, the mentor's qualifications and training record, the training environment, and the applicant's relevance to stem cell research. Applicants will be evaluated by an independent peer review committee comprised of scientifically recognized experts in the field of stem cell research that reside out of the State.

Questions by applicants about this RFA may only be addressed by email at mscrfinfo@MarylandTEDCO.org. More information about RFA-MD-07-3 requirements and the Maryland Stem Cell Research Fund can be found at http://www.MarylandTEDCO.org.


'/>"/>
SOURCE The Maryland Stem Cell Research Commission
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. BioSpace Career Fair in Bethesda, Maryland Draws Hundreds of Industry Professionals
2. Federal Trade Commission Clears Kyphons Acquisition of Non-Vertebroplasty Spine-Related Assets of Disc-O-Tech
3. Enigma Diagnostics Announces a European Commission Award of EUR3 Million to Fund the Development of a Point of Care Platform for the Rapid Diagnosis of Influenza Infections
4. Schering-Plough Receives Approval from European Commission for Planned Acquisition of Organon BioSciences N.V.
5. Poniard Pharmaceuticals Announces European Commission Grants Orphan Medicinal Product Designation to Picoplatin for Treatment of Small Cell Lung Cancer
6. Pharmos Issues Letter to Shareholders
7. MichBio Issues 2007/8 Michigan Life Sciences Directory and Resources Guide
8. HHS Issues First Department-Wide Report on Personalized Health Care
9. CalbaTech Issues Update; Beginning Training for Adult Stem Cell Collections in Atlanta
10. Symmetry Medical Discloses Accounting Issues at Sheffield, UK Operating Unit and Possible Restatement
11. CCPM Issues Statement on FDAs GIVE Initiative
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
(Date:6/23/2016)... Prostate Cancer Foundation (PCF) is pleased to announce 24 new Young ... cancer. Members of the Class of 2016 were selected from a pool of ... More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... ... June 23, 2016 , ... In a new case ... Denmark detail how a patient who developed lymphedema after being treated for breast cancer ... could change the paradigm for dealing with this debilitating, frequent side effect of cancer ...
Breaking Biology Technology:
(Date:6/9/2016)... leader in attendance control systems is proud to announce the introduction of fingerprint attendance ... the right employees are actually signing in, and to even control the opening of ... ... ... Photo - ...
(Date:6/2/2016)... The Department of Transport Management (DOTM) of ... Dollar project, for the , Supply and Delivery ... IT Infrastructure , to Decatur ... Identity Management Solutions. Numerous renowned international vendors participated in the ... was selected for the most compliant and innovative solution. The ...
(Date:5/24/2016)... , May 24, 2016 Ampronix facilitates superior patient care by providing ...  3D medical LCD display is the latest premium product recently added to the range ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
Breaking Biology News(10 mins):